Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06188286 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Patient-Controlled TEAS vs Sham TEAS for Improve Quality of Life in Patients With Cancer Pain

StatusNot Yet Recruiting
PhaseNot applicable
SponsorYi Liang
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 24, 2024 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2024 to Oct 31, 2025v4 Show 5 more changesShow less
    • Start date: Feb 1, 2024 to Dec 25, 2024
    • Primary endpoint revised
    • Study completion date: Jun 30, 2025 to Dec 30, 2025
    • Eligibility criteria shortened, about 33 words
    • Secondary endpoints: 9 to 6
  2. Start date: Jan 1, 2024 to Feb 1, 2024v3
  3. Primary endpoint revised
    • Secondary endpoints: 7 to 9
    • Study title shortened, about 3 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Yi Liang
5 trials monitored
See all monitored trials
The conduct of a pilot trial is of great significance as a means of assessing the feasibility and harmonization of the research and is a very necessary precursor to the better conduct of formal trials. The primary aim of this pilot study is to assess the feasibility of a PC-TEAS in improving the quality of life of cancer patients with pain, with the aspiration of providing process evidence base and an assessment of the intervention for conducting a formal trial. the secondary outcome is to assess the clinical efficacy of the PC-TEAS.
Trial Details
NCT Number NCT06188286
Lead Sponsor Yi Liang
Conditions
(from sponsor)		 Cancer Pain
Related terms Cancer Pain
Enrollment 94 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov